WO2023161746 - CONTINUOUS MONITORING SYSTEM OF CLINICAL CONDITIONS AND INTELLIGENT SELF-REGULATION OF CONTINUOUS INFUSION OF DRUGS
National phase entry is expected:
Publication Number
WO/2023/161746
Publication Date
31.08.2023
International Application No.
PCT/IB2023/051077
International Filing Date
07.02.2023
Title **
[English]
CONTINUOUS MONITORING SYSTEM OF CLINICAL CONDITIONS AND INTELLIGENT SELF-REGULATION OF CONTINUOUS INFUSION OF DRUGS
[French]
SYSTÈME DE SURVEILLANCE CONTINUE DE CONDITIONS CLINIQUES ET AUTO-RÉGULATION INTELLIGENTE DE PERFUSION CONTINUE DE MÉDICAMENTS
Applicants **
ABDOLLAHI, Mohammad
Unit 11 no 21 east daneshvar st north shiraz st vanak
Tehran, 1375673599, IR
NIKFAR, Shekoufeh
Unit 11 no 21 east daneshvar st north shiraz st vanak
Tehran, 1375673599, IR
ARABAMERY, Masoud
no 13 alley 18 moallem st
Shahroud, 3613636677, IR
SHARIFNIA, Mohammadhossein
unit 4 no 80 shahanghi st north sheykh bahayi
Tehran, 1993613755, IR
Inventors
ABDOLLAHI, Mohammad
Unit 11 no 21 east daneshvar st north shiraz st vanak
Tehran, 1375673599, IR
NIKFAR, Shekoufeh
Unit 11 no 21 east daneshvar st north shiraz st vanak
Tehran, 1375673599, IR
ARABAMERY, Masoud
no 13 alley 18 moallem st
Shahroud, 3613636677, IR
SHARIFNIA, Mohammadhossein
unit 4 no 80 shahanghi st north sheykh bahayi
Tehran, 1993613755, IR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1790 | |
| EPO | Filing, Examination | 8727 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 482 | |
| USA | Filing, Examination | 20110 |
Total: 31699 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
This is an invention composed of a coordinated monitoring system, predicting clinical conditions, and making decisions for changing the conditions of drug therapy interventions to improve the clinical conditions and the prognosis of patients' recovery, changes in the systemic resistance of the blood vessels. A collection of communication and operation of three different general systems, which are described as follows: - "Continuous monitoring of patients' hemodynamic conditions based on high-frequency ultrasonic waves and infrared waves" - "Intelligent infusion pump device with self-regulation capability in dosing and speed of drug injection" - "Software section designed for monitoring clinical conditions". The connection between the central processor (CPU) and, indeed, the "software section designed for monitoring the clinical conditions of the patients" claimed with the electronic module of the "ultrasonic detector" section has caused the continuous sending of information to the profile relating to patients in the hospital information system (HIS). Furthermore,[French]
La présente invention est composée d'un système de surveillance coordonné, de prédiction de conditions cliniques, et de prise de décisions pour modifier les conditions d'interventions de thérapie médicamenteuse pour améliorer les conditions cliniques et le pronostic de rétablissement de patients, les changements de la résistance systémique des vaisseaux sanguins. L'invention concerne un ensemble de communication et de fonctionnement de trois systèmes généraux différents, qui sont décrits comme suit : - "La surveillance continue des conditions hémodynamiques du patient sur la base d'ondes ultrasonores haute fréquence et d'ondes infrarouges" - "Un dispositif de pompe à perfusion intelligent ayant une capacité d'auto-régulation concernant le dosage et la vitesse d'injection du médicament" - "Une section logicielle conçue pour surveiller des conditions cliniques". La connexion entre le processeur central (CPU) et, en effet, la "section logicielle conçue pour surveiller les conditions cliniques des patients" revendiquée avec le module électronique de la section "détecteur ultrasonore" a provoqué l'envoi continu d'informations au profil concernant des patients dans le système d'informations hospitalières (HIS).